SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-16-095967
Filing Date
2016-02-11
Accepted
2016-02-11 16:33:08
Documents
1
Period of Report
2016-02-10

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 7323
  Complete submission text file 0001104659-16-095967.txt   8963
Mailing Address 33 LOCKE DRIVE MARLBOROUGH MA 01752
Business Address 33 LOCKE DRIVE MARLBOROUGH MA 01752 508-756-1212
Ocata Therapeutics, Inc. (Issuer) CIK: 0001140098 (see all company filings)

IRS No.: 870656515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NABI BIOPHARMACEUTICALS 5800 PARK OF COMMERCE BLVD., N.W. BOCA RATON FL 33487
Business Address
Jooste H Le Roux (Reporting) CIK: 0001312270 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36855 | Film No.: 161412045